Osaic Holdings’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $625K | Buy |
90,138
+47,159
| +110% | +$327K | ﹤0.01% | 2618 |
|
|
2025
Q1 | $143K | Sell |
42,979
-43,194
| -50% | -$144K | ﹤0.01% | 3903 |
|
|
2024
Q4 | $636K | Buy |
86,173
+49,529
| +135% | +$366K | ﹤0.01% | 2567 |
|
|
2024
Q3 | $344K | Buy |
36,644
+4,315
| +13% | +$40.5K | ﹤0.01% | 3205 |
|
|
2024
Q2 | $259K | Sell |
32,329
-16,834
| -34% | -$135K | ﹤0.01% | 3325 |
|
|
2024
Q1 | $729K | Buy |
49,163
+10,839
| +28% | +$161K | ﹤0.01% | 2624 |
|
|
2023
Q4 | $311K | Buy |
38,324
+21,924
| +134% | +$178K | ﹤0.01% | 3573 |
|
|
2023
Q3 | $74.6K | Sell |
16,400
-562
| -3% | -$2.56K | ﹤0.01% | 4722 |
|
|
2023
Q2 | $119K | Buy |
16,962
+103
| +0.6% | +$726 | ﹤0.01% | 4293 |
|
|
2023
Q1 | $103K | Buy |
16,859
+3
| +0% | +$18 | ﹤0.01% | 4426 |
|
|
2022
Q4 | $107K | Sell |
16,856
-5,484
| -25% | -$34.8K | ﹤0.01% | 4372 |
|
|
2022
Q3 | $214K | Buy |
22,340
+110
| +0.5% | +$1.05K | ﹤0.01% | 3672 |
|
|
2022
Q2 | $245K | Sell |
22,230
-1,049
| -5% | -$11.6K | ﹤0.01% | 3589 |
|
|
2022
Q1 | $388K | Sell |
23,279
-977
| -4% | -$16.3K | ﹤0.01% | 3470 |
|
|
2021
Q4 | $463K | Sell |
24,256
-1,258
| -5% | -$24K | ﹤0.01% | 3142 |
|
|
2021
Q3 | $628K | Buy |
25,514
+202
| +0.8% | +$4.97K | ﹤0.01% | 2801 |
|
|
2021
Q2 | $659K | Buy |
25,312
+717
| +3% | +$18.7K | ﹤0.01% | 2729 |
|
|
2021
Q1 | $779K | Buy |
24,595
+13,115
| +114% | +$415K | ﹤0.01% | 2444 |
|
|
2020
Q4 | $533K | Sell |
11,480
-206
| -2% | -$9.56K | ﹤0.01% | 2584 |
|
|
2020
Q3 | $380K | Buy |
11,686
+249
| +2% | +$8.1K | ﹤0.01% | 2684 |
|
|
2020
Q2 | $314K | Buy |
11,437
+333
| +3% | +$9.14K | ﹤0.01% | 2732 |
|
|
2020
Q1 | $332K | Buy |
+11,104
| New | +$332K | ﹤0.01% | 2435 |
|